Ben Tre Pharmaceutical JSC (DBT) — Cash Flow Reinvestment Rate
Ben Tre Pharmaceutical JSC (DBT) has a Cash Flow Reinvestment Rate of 0.03x as of June 2020, reinvesting ₫1.27 Billion (capex ₫87.53 Million plus investments ₫-1.18 Billion) from operating cash flow of ₫37.04 Billion. Explore Ben Tre Pharmaceutical JSC capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ben Tre Pharmaceutical JSC Cash Flow Reinvestment Rate (2016–2017)
Historical reinvestment intensity for Ben Tre Pharmaceutical JSC across 2 annual periods. Check Ben Tre Pharmaceutical JSC earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Annual Cash Flow Reinvestment Rate for Ben Tre Pharmaceutical JSC (2016–2017)
Year-by-year capital reinvestment analysis for Ben Tre Pharmaceutical JSC. For live market cap and broader valuation context, see how much is Ben Tre Pharmaceutical JSC worth.
| Year | Reinvestment Rate | Total Reinvested (VND) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 0.80x | ₫40.69 Billion | ₫51.07 Billion | ₫9.02 Billion | ▼ -29.1% |
| 2016 | 1.12x | ₫36.73 Billion | ₫32.71 Billion | ₫4.50 Billion | — |